By using an ACSL inhibitor TrC, we surprisingly found the potential anti-inflammatory properties of stroke-associated microglial LDs and further confirmed the neuroprotective effects of an ATGL inhibitor Atglistatin in ischemic stroke. Here, PNPLA2 is linked to stroke disorder.